Novo Nordisk Sues Over Copycat Semaglutide, Points to Serious Adverse Reactions

Novo Nordisk has sued nine more companies for selling products billed as containing semaglutide, a primary ingredient in the Danish pharma’s popular weight loss drug Wegovy.
Source: Drug Industry Daily